AstraZeneca completes USD2bn equity investment in Summit Therapeutics

GE HealthCare to acquire SOFIE Biosciences for USD945m

Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages

MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK

AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations

Fuse Oncology and Associated Medical Professionals of NY launch FuseRx proof of concept

Leo Cancer Care invests in children's experience of radiotherapy, following world-first treatments

Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer

FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma

AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer

UChicago Medicine completes construction phase of new cancer facility

FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test

Astellas doses first patient in Phase 3 lung cancer study

X-Chem and Relay Therapeutics collaborate on Phase 3 milestone